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abstraCt
introduction: Previous studies have found partners’ smoking status, multiparity, and nicotine dependence to be associated with 
smoking cessation in pregnancy. However, no studies have investigated influences on cessation among women using nicotine 
replacement therapy (NRT). We analyzed data from a trial of NRT in pregnancy to determine factors associated with shorter- and 
longer-term cessation.
Methods: Data were collected at baseline, 1 month, and delivery from 1,050 pregnant women. Two multivariable logistic 
models for validated cessation at 1 month and delivery were created with a systematic strategy for selection of included factors.
results: All findings are from multivariable analyses. At 1 month, odds of cessation were greater among those who completed 
full time education at >16 years of age (odds ratio [OR] = 1.82, 95% confidence interval CI = 1.24–2.67, p = .002) but they 
were lower in women with higher baseline cotinine levels (OR = 0.93, 95% CI = 0.90–0.95, p < .001). At delivery, the odds of 
cessation were greater among those who completed full time education at >16 years of age (OR = 1.89, 95% CI = 1.16–3.07, 
p = 0.010) but were inversely associated with higher baseline cotinine levels (OR = 0.96, 95% CI = 0.92–0.99, p = .010).
Conclusions: Women who are better educated and have lower pretreatment cotinine concentrations had higher odds of stop-
ping smoking and factors associated with shorter and longer term cessation were similar.
intrOduCtiOn
Smoking in pregnancy is a significant public health problem. 
In the United Kingdom, a country with strong tobacco control 
culture, a survey in 2011 found that 26% of pregnant women 
smoked at some point before or during pregnancy and 12% 
smoked constantly throughout gestation (Eastwood, 2011). As 
smoking is a completely preventable cause of poor health out-
comes for mothers and their babies, stopping smoking before 
or during pregnancy is vital. Unfortunately, though, there are 
few evidence-based cessation interventions that are proven to 
work for cessation in pregnancy.
A systematic review investigating the predictors of quit 
attempts made by nonpregnant smokers, found that a lower 
number of previous quit attempts and higher levels of nico-
tine dependence were both inversely associated with cessation 
(Vangeli, Stapleton, Smit, Borland, & West, 2011). Factors that 
have been associated with increased number of quit attempts in 
pregnancy also include age and smoking duration (Yu, Park, & 
Schwalberg, 2002). However, a recent systematic review found 
that having a partner who smoked, multiparity and increasing 
nicotine dependence had, in many studies, been found inversely 
associated with likelihood of achieving cessation (Schneider, 
Huy, Schutz, & Diehl, 2010). Additionally, socioeconomic 
factors such as increased income and educational levels of the 
mother and partner have also been shown to be associated with 
cessation in pregnancy (Ebert & Fahy, 2007; Mohsin & Bauman, 
2005; Schneider et al., 2010), but these associations may be due 
to decline in smoking rates, which has been found to be lower in 
women from lower socioeconomic groups (US DHHS, 2004). 
Data from surveys conducted in the United Kingdom and Spain 
have also found that pregnant women with lower educational 
and socioeconomic levels have lower chances of cessation, 
whereas women who smoked fewer cigarettes, started smoking 
at an older age, had a partner who did not smoke or were primi-
parous were more likely to quit (Torrent et al., 2004).
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Factors associated with smoking cessation in pregnancy
There is less evidence, though, about which factors might 
influence women’s success when using nicotine replacement 
therapy (NRT) in cessation attempts made during pregnancy. 
Although nicotine dependence appears central to maintaining 
smoking behavior in pregnancy, attempts to promote cessa-
tion in pregnancy by addressing this with NRT have thus far 
been unsuccessful (Coleman, Chamberlain, Davey, Cooper, & 
Leonardi-Bee, 2012a). Further investigation of factors asso-
ciated with cessation in pregnancy is warranted and analyses 
using data from studies in which an attempt has been made to 
treat nicotine dependence would be particularly informative. 
Recently, the Smoking, Nicotine, and Pregnancy (SNAP) trial, 
a large trial investigating the use of NRT for smoking cessa-
tion in pregnancy was conducted (Coleman et al., 2012b), and 
using the cohort of participants from this trial, we investigate 
independent associations between participants’ baseline char-
acteristics and cessation at both early and late follow-up points 
to help ascertain whether or not any might be potential deter-
minants of successful cessation.
MethOds
Data Source
Data for explanatory variables in these analyses were collected 
at baseline and outcome variable data were collected at two 
subsequent follow-up points within the SNAP trial (Coleman 
et  al., 2012b). Trial participants were aged 16–45  years; of 
12–24 weeks gestation; smoked ≥10 cigarettes prior to preg-
nancy and smoked ≥5 cigarettes currently; and had exhaled 
carbon monoxide (CO) readings of >8 parts per million (ppm).
Treatment Protocol
Between May 2007 and February 2010, 1,050 participants 
were recruited to the trial from seven English hospital antenatal 
clinics. Research midwives collected baseline data, prescribed 
trial patches and provided face-to-face behavioral support at 
enrollment, and collected follow-up data at contacts; 1 month 
and delivery. Women received a behavioral support session 
lasting up to 1 hr at enrollment. A quit date was also set within 
2 weeks of enrollment and the follow-up points were measured 
from this. Women were offered additional behavioral support 
from the local National Health Service (NHS) stop smoking 
services throughout the trial to all participants according to the 
national standards, and research midwives provided telephone 
support when women were contacted on their quit date, 3 days 
after this and at 1  month. Participants were randomized to 
receive either NRT (15 mg/16 hr) or identical placebo patches. 
The first 4 weeks supply of patches was issued on the quit 
date, with a second batch of 4 weeks of patches given to those 
women reported not smoking and who had CO validation at 
the 1-month follow-up. Full methods (Coleman et al., 2012b) 
including the initial (Coleman et al., 2007) and final (Coleman 
et al., 2009) protocols for this study are published elsewhere.
Baseline Data: Explanatory Variables
Prior to randomization, the following data were collected from 
participants: date of birth, ethnicity, age on completion of full 
time education, partner’s smoking status, parity, gestational 
age, body mass index, and previous use of NRT during their 
current pregnancy. Saliva and blood samples were taken for 
cotinine estimation, along with exhaled CO readings to esti-
mate smoke and nicotine intake, respectively. Trial recruitment 
site and participants’ treatment assignment (i.e., NRT or pla-
cebo) were also available from the trial database.
Outcome Variables
For analyses in this paper, we used validated cessation at 1-month 
postquit date and at delivery as outcome variables. At 1 month, 
cessation was defined as continuous abstinence from quit date to 
1 month, validated by an exhaled CO reading of ≤8 ppm; and, at 
delivery, cessation was defined as continuous abstinence from a 
quit date until delivery, validated by an exhaled CO reading of 
≤8 ppm and/or a saliva cotinine level of <10 ng/ml. Participants 
who were lost to follow-up were coded as continuing smokers.
Analysis Strategy
This analysis investigated associations between baseline charac-
teristics of participants and cessation at 1 month after initiating 
treatment (i.e., from quit date) and at delivery. Two multivariable 
logistic models were built. Initially, for both models, variables 
were identified which had significant univariate associations 
(p ≤ .05) with validated cessation at each timepoint. Secondly, 
these variables were all entered into a multivariable model using 
stepwise backwards elimination to remove variables found 
to have nonsignificant associations with outcome (p > .05). 
Finally, variables which showed no association at the univari-
ate level were entered into the models individually, to determine 
if they were subsequently associated with validated cessation. 
Treatment assignment was included as an a-priori confounder.
To maximize the number of participants included in the anal-
ysis, where possible, a missing category was created for categor-
ical variables with missing data and imputation was planned for 
continuous variables (baseline cotinine) where >10% of cases 
had missing data. Where all missing values for an exposure 
occurred among people in the same outcome category (i.e., con-
tinuing smokers) or a small percentage of data was missing for a 
continuous variable, a univariate sensitivity analysis comparing 
all participants against those with complete data was conducted, 
to verify that they did not differ in their baseline characteristics.
All analyses were conducted using Stata 11.2 (College 
Station, TX).
results
In the 1 month and delivery multivariate analyses, missing data 
for the categorical variable “age full time education finished” 
could not be included as all those with missing data were 
smokers at follow-up and inclusion as an extra category would 
perfectly predict the outcome. Furthermore, imputation for the 
continuous variable “baseline cotinine level” was not carried 
out due to data being missing for only 80 participants (7.6%). 
As a result, analysis was undertaken on 957/1,050 participants 
(91.1%), for whom complete exposure data were available. 
Including the 93 participants for whom some baseline data 
were missing in the final multivariable model, did not alter 
the results. An analysis based on achieving validated cessation 
was conducted and characteristics of the women included are 
detailed in Table 1. At 1 month 167 (17.5%), and at delivery 84 
(8.8%) of the participants achieved validated cessation.
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Factors Associated With Smoking Cessation at 1 Month
At 1  month, in the univariate analysis, women who finished 
full time education when they were >16 years had greater odds 
of cessation; women who had a higher baseline cotinine lev-
els, and those who were recruited from trial site 4, were found 
to have lower odds of cessation (Table 2). The final multivari-
able model shows which baseline variables were independently 
associated with validated cessation at 1 month. Women who 
were aged >16  years when they finished full time educa-
tion (odds ratio [OR] = 1.82, 95% confidence interval [CI] = 
1.24–2.67, p  =  .002) had significantly increased odds of 
achieving validated cessation. Participants who had a higher 
baseline cotinine (OR = 0.94, 95% CI = 0.91–0.96, p < .001 for 
a 10 ng/ml increase) had significantly lower odds of cessation 
at 1 month after quit date. The effect of trial recruitment site 
4 did not remain significant when added to the multivariable 
model (OR = 0.69, 95% CI = 0.36–1.34, p = .277).
Factors Associated With Smoking Cessation at Delivery
Table 3 shows the univariable and multivariable associations 
with validated cessation at delivery; the univariable results 
found women who finished full time education at >16 years 
and had lower baseline cotinine levels had increased odds of 
cessation and those with higher baseline cotinine levels had 
lower odds of cessation. In the final multivariable model, 
women who continued school beyond the compulsory mini-
mum age (16 years) were more likely to stop smoking (OR = 
1.89, 95% CI = 1.16–3.07, p = .010) and women with a higher 
baseline cotinine level were less likely to achieve cessation 
(OR = 0.96, 95% CI = 0.92–0.99, p < .010).
disCussiOn
Main Findings
We found that, among participants in a trial of transdermal 
nicotine patches in pregnancy, smoking cessation of 1-month 
duration and also until delivery were positively associated 
with finishing full time education beyond the compulsory age 
of 16  years and negatively associated with baseline cotinine 
levels. Leaving school at 16 years is a marker of social disad-
vantage and also an indicator of lower socioeconomic status, 
which is associated with decreased probability of quitting.
Strengths and Limitations
The main limitation of this study was that a relatively restricted 
variety of variables were collected in the trial; in particular, 
there were few behavioral or socioeconomic measures, which, 
in some studies have been shown to influence cessation 
(Schneider et  al., 2010). It also remains possible that differ-
ences in cessation rates observed in early and late pregnancy 
might be explained by unmeasured factors. Furthermore, as 
a number of significance tests were performed, some of the 
observed associations may have occurred by chance (i.e., Type 
I errors). However, as this is the first analysis employing mul-
tivariable methods to determine factors which were indepen-
dently associated with smoking cessation in a trial of NRT 
patches, findings remain interesting. Additionally, our study 
sample was large and was mostly complete, permitting inclu-
sion of 91% of trial participants in analyses. This will have 
increased the likelihood that weak associations between base-
line factors and validated cessation in the trial database could 
be discovered. A final advantage of investigating predictors in 
a trial of NRT is that biochemically validated cessation was 
used; accuracy of self-reported cessation in pregnancy is typi-
cally low due to the perceived social acceptability of smoking 
during pregnancy.
Findings in the Context of Previous Work
Two previous systematic reviews, in nonpregnant (Vangeli 
et  al., 2011) and pregnant smokers (Schneider et  al., 2010), 
respectively, have investigated predictors of smoking ces-
sation. Both found that nicotine dependence is an important 
predictor of quit attempt success, with higher levels reducing 
the likelihood of a successful quit attempt. Our analyses pro-
vide complementary data showing, in the context of an NRT 
trial, that lower cotinine concentration increased the odds of 
table 1. Participant Characteristics for Cessation at 1 Month and Delivery
Variable
One month Delivery
Smoking (n = 790) Abstinent (n = 167) Smoking (n = 873) Abstinent (n = 84)
Age (median [IQR]) 
(years)
25 (21–30) 25 (21–31) 25 (21–30) 25 (21–31)
Primiparous 36.8% 37.1% 36.3% 42.9%
Age full-time education 
finished (years)
 ≤16 80.5% 68.9% 79.6% 66.7%
 >16 19.5% 31.1% 20.4% 33.3%
Ethnicity
 British: White 97.3% 96.4% 97.4% 95.2%
 Other 2.7% 3.6% 2.6% 4.8%
Gestational age (median 
[IQR]) (weeks)
15 (13–18) 15 (13–18) 15 (13–18) 15 (13–20)
Baseline cotinine (median 
[IQR]) (ng × 10−1/ml)
12.7 (8.7–18.2) 9.1 (5.8–13.8) 12.4 (8.1–17.8) 10.6 (6.0–15.3)
Note. IQR = interquartile range.
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Factors associated with smoking cessation in pregnancy
cessation among trial participants in both early and late preg-
nancy. Cotinine levels are a marker of tobacco smoke exposure 
rather than being a measure of nicotine dependence. However, 
within these trial participants both plasma and saliva measures 
of cotinine have been found to be highly correlated with a vali-
dated measure of nicotine dependence in pregnancy (Kwok, 
Taggar, Cooper, Lewis, & Coleman, 2013), so it is likely that, 
lower levels of nicotine dependence, would also increase the 
likelihood of women in this study quitting too.
The previous reviews also investigated associations between 
socioeconomic factors and smoking cessation and found strong 
evidence for a positive association between higher socioeco-
nomic status or, higher income levels and cessation in preg-
nancy (Schneider et al., 2010); but little evidence was found for 
an association between income, level of education or employ-
ment status, and cessation in nonpregnant smokers (Vangeli 
et al., 2011). The present study concurs with the previous find-
ings that higher levels of social disadvantage are associated 
with worse outcomes in pregnant women who attempted cessa-
tion as part of an NRT trial.
In the previous review that investigated pregnant smokers’ 
quit attempts, all included studies used self-reported cessa-
tion measures (Schneider et  al., 2010), which may be prone 
to underreporting of smoking behavior due to social desirabil-
ity bias and, so, the validity of findings from empirical studies 
included in this review could be questioned. As nonsmokers 
are unlikely to report themselves as smokers, misclassification 
of women currently smoking as nonsmokers could bias the 
strength of associations between factors relating to smoking 
behavior and addiction and those measuring social disadvan-
tage and cessation toward the null. In our dataset, misclassi-
fication of smoking status due to such biases in self-reported 
data cannot have occurred; consequently, our demonstration of 
the importance of nicotine dependence and social disadvantage 
to smoking cessation is likely to be valid.
Only one previous report has used validated cessation data 
to investigate factors associated with successful cessation in 
pregnancy (Fish et  al., 2009). This analysis used data from 
the U.S. “Baby Steps” trial (Pollak et  al., 2007) and found 
that women who were primiparous and who used more NRT 
were more likely to report cessation at 38 weeks gestation 
(Fish et al., 2009); however, the study sample was small (104 
women) and only univariable associations were reported, so 
these findings are difficult to interpret. Our much larger study 
has greater power and used a multivariable analysis, which 
investigated the independent associations with cessation.
The analyses presented in this paper suggest that, in preg-
nant women who use NRT to attempt cessation, higher levels 
of social disadvantage and higher pretreatment cotinine levels 
are associated with worse cessation outcomes. It is possible 
that both associations are causal, though a mechanism for 
cotinine concentration affecting cessation through its contri-
bution to nicotine dependence is more immediately obvious. 
Outside of pregnancy, nicotine dependence is also more eas-
ily remedied, for example, by NRT, which has been shown to 
reduce the strength of craving and be effective (Stead, Perera, 
Mant, & Lancaster, 2008). These findings have research impli-
cations; further work investigating how socioeconomic status 
may influence success in quit attempts could uncover factors 
that are amenable to intervention. Similarly, further research 
into the treatment of nicotine dependence may be indicated; 
there is currently no evidence that NRT is effective in preg-
nancy (Coleman et al., 2012a), but future studies using higher 
doses of nicotine than those which have been trialed could 
be undertaken. Nicotine metabolism is faster in pregnancy 
(Dempsey, Jacob, & Benowitz, 2002) and the standard doses 
of NRT that have been investigated may be too low to be effec-
tive. The finding that increasing cotinine concentration, which 
is strongly correlated with nicotine dependence (Kwok et al., 
2013), is strongly associated with cessation failure should pro-
vide a spur to investigate this possibility.
Conclusions and Recommendations
Among pregnant participants in a trial of NRT for smoking ces-
sation, women who were not educated beyond the compulsory 
age for finishing school and those who had higher pretreatment 
cotinine concentrations were less likely to stop smoking through-
out pregnancy. Women with these characteristics may require a 
different kind of smoking cessation support in pregnancy than 
others; however, it is not possible, from our data, to determine 
the nature of support that these women would find most helpful.
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